46.Wright,
Robin. ”How
Iran Became a New Epicenter of the Coronavirus Outbreak”. The New
Yorker. Archived from
the original on 3 March 2020. Retrieved 7 March 2020.
47. Jump
up
to:a b c ”Iran
Coronavirus”. Worldometer. Archived from
the original on 9 March 2020. Retrieved 23 March 2020.
47. Jump
up
to:a b c ”Iran
Coronavirus”. Worldometer. Archived from
the original on 9 March 2020. Retrieved 23 March 2020.
48. Jump
up
to:a b c ”Iran
Reports Its First 2 Cases of the New Coronavirus”. New York
Times. Archived from the original on 19
February 2020. Retrieved 19 February 2020.
49. Jump
up
to:a b c ”How
Iran Became a New Epicenter of the Coronavirus Outbreak”. The New
Yorker. Archived from
the original on 3 March 2020. Retrieved 5 March 2020.
50.Monajjemi, M.; Shahriari, S.; Mollaamin, F. Evaluation of Coronavirus
Families & Covid-19 Proteins:
Molecular Modeling Study. Biointerface Res. Appl. Chem. 2020, 10,
6039-6057,
https://doi.org/10.33263/BRIAC105.60396057.
51. Roy, A.; Kucukural, A.; Zhang, Y. I-TASSER: a unified platform for
automated protein structure and
function prediction. Nature Protocols 2010, 5, 725-738,
https://doi.org/10.1038/nprot.2010.5.
52. Molecular Operating Environment (MOE), 2019.01; Chemical Computing
Group ULC, 1010 Sherbrooke
St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2019.
53. Báez-Santos, Y.M.; Barraza, S.J.; Wilson, M.W.; Agius, M.P.;
Mielech, A.M.; Davis, N.M.; Baker, S.C.; Larsen, S.D.; Mesecar, A.D.
X-ray Structural and Biological Evaluation of a Series of Potent and
Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases.
Journal of Medicinal Chemistry 2014, 57,
2393-2412 https://doi.org/10.1021/jm401712t.
54.Li ZY, Meng LY. 2020. Prevention and control of new coronavirus
infection2020] in press. doi:10.3760/cma.j.issn.1002-0098.2020.0001
Andersson L, Andreasen JO, Day P, Heithersay G, Trope M, DiAngelis AJ
Kenny DJ, Sigurdsson A, Bourguignon C, Flores MT. 2012. International
55.Association of Dental Traumatology guidelines for the management of
traumatic dental injuries: 2. Avulsion of permanent teeth. Dent
Traumatol.
28(2):88–96.
56.Centers for Disease Control and Prevention. 2020. Disease burden of
influenza;
[accessed 2020 Feb 25].
https://www.cdc.gov/flu/about/burden/index.html.
Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC,
Poon
RW, et al. 2020. A familial cluster of pneumonia associated with the
2019
novel coronavirus indicating person-to-person transmission: a study of a
family cluster. Lancet. 395(10223):514–523.
57.National Health Commission of China. 2020a. The diagnosis and
treatment
protocol for novel coronavirus pneumonia (interim sixth edition)
[accessed
2020 Feb 19]. http://www.gov.cn/zhengce/zhengceku/2020-02/19/content
58.The Chinese Preventive Medicine Association. 2020. An update on the
epide-
miological characteristics of novel coronavirus pneumonia (COVID-19).
Chin J Epidemiol. 41(2):139–144.
59.Abdollahi, A., et al. (2020). ”The Novel Coronavirus SARS-CoV-2
Vulnerability Association with ABO/Rh Blood Types.” Iranian Journal of
Pathology: 156-160.
60.AL-Khikani, F. H. O. (2020). ”The role of blood group in COVID-19
infection: More information is needed.” Journal of Nature and Science of
Medicine 3(3): 225.
61.Ali, S. A., et al. (2020). ”The outbreak of Coronavirus Disease 2019
(COVID-19)—An emerging global health threat.” Journal of infection and
public health.
62.Alraddadi, B. M., et al. (2016). ”Risk factors for primary Middle
East respiratory syndrome coronavirus illness in humans, Saudi Arabia,
2014.” Emerging infectious diseases 22(1): 49.
63.Amin, P., et al. (2018). ”Regulation of a distinct activated RIPK1
intermediate bridging complex I and complex II in TNFα-mediated
apoptosis.” Proceedings of the National Academy of Sciences 115(26):
E5944-E5953.
64.Anvari, M. S., et al. (2009). ”ABO blood group and coronary artery
diseases in Iranian patients awaiting coronary artery bypass graft
surgery: a review of 10,641 cases.” Laboratory Medicine 40(9): 528-530.
65.Ashraf, M. A., et al. (2020). ”COVID-19 in Iran, a comprehensive
investigation from exposure to treatment outcomes.” medRxiv.
66.Bener, A. and M. Yousafzai (2014). ”The distribution of the ABO blood
groups among the diabetes mellitus patients.” Nigerian journal of
clinical practice 17(5): 565-568.
67.Cai, H., et al. (2020). ”Psychological Impact and Coping Strategies
of Frontline Medical Staff in Hunan Between January and March 2020
During the Outbreak of Coronavirus Disease 2019 (COVID19) in Hubei,
China.” Med Sci Monit 26: e924171.
68.Cakebread, J. A., et al. (2011). ”Exogenous IFN-β has antiviral and
anti-inflammatory properties in primary bronchial epithelial cells from
asthmatic subjects exposed to rhinovirus.” Journal of Allergy and
Clinical Immunology 127(5): 1148-1154. e1149.
69.Chan, J. F.-W., et al. (2020). ”Genomic characterization of the 2019
novel human-pathogenic coronavirus isolated from a patient with atypical
pneumonia after visiting Wuhan.” Emerging microbes & infections 9(1):
221-236.
70.Chen, L., et al. (2020). ”Convalescent plasma as a potential therapy
for COVID-19.” The Lancet Infectious Diseases 20(4): 398-400.
71.Cooling, L. (2015). ”Blood groups in infection and host
susceptibility.” Clinical microbiology reviews 28(3): 801-870.
72.Cui, J., et al. (2019). ”Origin and evolution of pathogenic
coronaviruses.” Nature Reviews Microbiology 17(3): 181-192.
73.Dhama, K., et al. (2020). ”Coronavirus disease 2019–COVID-19.”
74.Fagherazzi, G., et al. (2015). ”ABO and Rhesus blood groups and risk
of type 2 diabetes: evidence from the large E3N cohort study.”
Diabetologia 58(3): 519-522.
75.Garrison, R., et al. (1976). ”ABO blood group and cardiovacular
disease the Framingham study.” Atherosclerosis 25(2-3): 311-318.
76.Gérard, C., et al. (2020). ”COVID‐19 & ABO blood group: another
viewpoint.” British journal of haematology.
77.Greenberg, S. B. (2016). Update on human rhinovirus and coronavirus
infections. Seminars in respiratory and critical care medicine, Thieme
Medical Publishers.
78.Hamming, I., et al. (2004). ”Tissue distribution of ACE2 protein, the
functional receptor for SARS coronavirus. A first step in understanding
SARS pathogenesis.” The Journal of Pathology: A Journal of the
Pathological Society of Great Britain and Ireland 203(2): 631-637.
79.Jassim, W. (2012). ”Association of ABO blood group in Iraqis with
hypercholesterolaemia, hypertension and diabetes mellitus.” EMHJ-Eastern
Mediterranean Health Journal, 18 (8), 888-891, 2012.
80.Kearney, P. M., et al. (2005). ”Global burden of hypertension:
analysis of worldwide data.” The lancet 365 (9455): 217-223.
81.Kumar, S., et al. (2020). Morphology, Genome Organization,
Replication, and Pathogenesis of Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19),
Springer: 23-31.
82.Mailles, A., et al. (2013). ”First cases of Middle East Respiratory
Syndrome Coronavirus (MERS-CoV) infections in France, investigations and
implications for the prevention of human-to-human transmission, France,
May 2013.” Eurosurveillance 18 (24): 20502.
83.Motlagh, A., et al. (2020). ”COVID19 prevention & care; a cancer
specific guideline.” Archives of Iranian Medicine 23 (4):
255-264.
84.Muniyappa, R. and S. Gubbi (2020). ”COVID-19 pandemic, coronaviruses,
and diabetes mellitus.” American Journal of Physiology-Endocrinology and
Metabolism 318 (5): E736-E741.
85.Okeke, C. O., et al. (2018). ”Variations in activated partial
thromboplastin time and prothrombin time in individuals of A, B, AB, and
O blood groups.” Iraqi Journal of Hematology 7 (2): 85.
86.Rabenau, H., et al. (2005). ”Stability and inactivation of SARS
coronavirus.” Medical microbiology and immunology 194(1-2): 1-6.
87.Singhal, T. (2020). ”A review of coronavirus disease-2019
(COVID-19).” The Indian Journal of Pediatrics: 1-6.
88.Wu, J. T., et al. (2020). ”Estimating clinical severity of COVID-19
from the transmission dynamics in Wuhan, China.” Nature Medicine 26(4):
506-510.
89.Xia, S., et al. (2020). ”Inhibition of SARS-CoV-2 (previously
2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor
targeting its spike protein that harbors a high capacity to mediate
membrane fusion.” Cell research 30(4): 343-355.
90.Zhang, W., et al. (2020). ”Molecular and serological investigation of
2019-nCoV infected patients: implication of multiple shedding routes.”
Emerging microbes & infections 9 (1): 386-389.
91.Zhao, J., et al. (2020). ”Relationship between the ABO Blood Group
and the COVID-19 Susceptibility.” medRxiv.